Ellyn L. Sternfield

Attorney in Washington, DC
Ellyn has more than 30 years of legal experience, with an extensive background in the field of government health care enforcement.

Ellyn's experience enables her to provide valuable insight to clients facing potential state or federal investigations, or who have general compliance concerns. Ellyn currently represents a variety of health care product and service providers in federal and state administrative, civil, and criminal matters around the country. She conducts internal reviews and investigations for clients concerned about potential compliance issues, including compliance investigations having to do with data security and privacy safeguards. Ellyn advises clients on proposed or existing health care business arrangements, especially those involving Medicaid, Medicare, and the 340B Drug Pricing Program. Ellyn drafts compliance plans to help insulate clients from future whistleblower claims or enforcement efforts. And Ellyn helps negotiate resolutions of matters brought under federal or state false claims acts.

Prior to joining Mintz Levin, Ellyn spent more than 15 years as the director of the Oregon Department of Justice's Medicaid Fraud Control Unit, supervising investigations and prosecutions of criminal and civil health care billing fraud and patient neglect cases in both state and federal court. Ellyn handled a wide variety of complex health care cases, and developed specialized experience in qui tam false claims actions. Ellyn was the lead state attorney in multiple “global” health care matters, heading up major false claims investigations and settlements involving national and international health care providers. Ellyn co-chaired the National Association of Medicaid Fraud Control Units (NAMFCU) Global Case Committee for more than 10 years, and was instrumental in developing the processes in use today for coordinating federal and state false claims investigations. She also developed and presented training programs for government attorneys, auditors, and investigators who investigate and pursue false claims health care cases.

Ellyn previously served as the chief of the Consumer Rights Division of the Office of the Utah Attorney General, overseeing administrative, civil, and criminal consumer-based investigations and litigation. Ellyn began her legal career as a defense attorney with the Clayton, Missouri firm of Wolff and Frankel.

Ellyn frequently speaks and writes on health care fraud and abuse matters, and is a contributor to the Mintz Levin Health Law & Policy Matters blog.

Newsroom
• Mintz Levin Attorneys Theresa C. Carnegie and Ellyn L. Sternfield to Speak at Pharmacy Benefit Oversight and Compliance Congress , (11.10.2014)
•Quoted in CMS Final Rule Firms up Fraud Controls over Managed Care, Part D Drug Benefit, Bloomberg BNA's Health Law Resource Center (05.28.2014)
• Mintz Levin Attorney Ellyn L. Sternfield to Speak at American ConferenceInstitute's National Forum on Pharmaceutical Compliance and Enforcement , (03.19.2014)
• Mintz Levin Attorney Ellyn L. Sternfield to Present at American Conference Institute's Advanced Forum on Healthcare Provider Disputes , (03.05.2014)
•Quoted in Lawyers Say Drugmakers May Follow GSK Marketing Overhaul, Reuters (12.18.2013)
•Quoted in GlaxoSmithKline Announces Changes to Global Sales, Marketing Practices, BNA's Pharmaceutical Law & Industry Report (12.17.2013)
•Quoted in Delays Expected As Result of Furloughs at FDA, HRSA, Modern Healthcare (10.01.2013)
•Quoted in Law Firm Launches App for Whistleblowers, Reuters (09.27.2013)
•Quoted in Courts Rein in FCA Suits over Medicare Billing Mistakes , Law360 (09.09.2013)
•Quoted in FCA's Reach at Stake as DOJ Jumps into 1st Circ. Fight , Law360 (08.14.2013)
•Quoted in CMS Announces First Temporary Moratoria for Medicare Provided, Supplier Enrollment , BNA's Health Care Fraud Report (08.07.2013)
•Quoted in Orphan Drug Rule Raises Off-Label Worries for Drug Makers , Reuters (07.31.2013)
•Quoted in Court Overturns $11 Million False Claims Act Award in Medicare Case, Inside Counsel (06.01.2013)
•Quoted in HR Crucial in Protecting Companies from Whistleblowers Lawsuits, Attorneys Say, BNA's Health Care Fraud Report (05.29.2013)
•Quoted in OIG Final Rule Allows State MFCUs to Use Federal Funding for Data Mining Technology , BNA's Health Care Fraud Report (05.29.2013)
•Quoted in States Pressured to Match Their False Claims Acts to Federal Law, Reuters (05.24.2013)
•Quoted in OIG Issues New Guidance for Healthcare Companies on Excluded Workers, Reuters (05.09.2013)
• Mintz Levin Attorney Ellyn L. Sternfield to Moderate Panel at ACI's In-House Counsel Forum on Government Regulation of Prescription Drug Pricing , (02.22.2013)
•Quoted in What Do the Election Results Mean for Medicaid? , Lawyers.com (11.15.2012)
• Mintz Levin Attorney Ellyn L. Sternfield to Moderate Panel at ACI's In-House Counsel Forum on Prescription Drug Pricing , (05.10.2012)
• Mintz Levin Attorney Ellyn L. Sternfield to Speak at Commercialization and Market Access Congress , (11.28.2011)
• Mintz Levin Attorney Ellyn L. Sternfield on Faculty of National Institute on Health Care Fraud , (03.22.2011)
• Ellyn L. Sternfield Joins Mintz Levin's Washington D.C. Office , (11.16.2010)

Awards & Recognitions
•HHS OIG Integrity Award (2005)
•President's Council on Integrity and Excellence Award for Excellence (2005)
•Multiple Oregon Department of Justice Outstanding Service Awards
•NAMFCU President's Leadership Award
•NAMFCU Case Leadership Award

Publications
•Co-author, CMS Proposes Major Changes to Medicare Part C and Part D , BNA's Medicare Report (03.07.2014)
•Co-author, CMS Proposes Major Rule Changes to Increase Payment Accuracy and Improve Program Integrity in Medicare Part C and Part D , BNA's Health Care Fraud Report (03.05.2014)
•Co-author, CMS Proposes Major Changes to Medicare Parts C and D , Health Law Advisory (01.21.2014)
•Author, Five Takeaways from the OIG's Special Advisory Bulletin on Exclusion , Health Law Advisory (05.10.2013)
•Author, The Pressure Is On For 340B Entities , Law360 (03.04.2013)
•Co-author, Sanctions Imposed on Qui Tam Counsel for Failing to Meet Ethical Standards Relating to the Use of Privileged Documents , Health Care Enforcement Defense Advisory (01.23.2012)
•Author, In Pursuit of Individual Exclusions, Law360 (08.2011)
•Co-author, The Government Announces Predictive Modeling Technology for Medicare To Go Live on July 1, 2011 , Health Care Enforcement Defense Alert (06.21.2011)
•Co-author, ACO Fraud & Abuse Provisions , Health Care Reform Advisory (05.06.2011)
•Co-author, HHS Boosts State Health Care Enforcement Authorities , Health Care Enforcement Defense Advisory (03.23.2011)
•Co-author, FDA to Begin Revamping the 510(k) Medical Device Review Program , Life Sciences Advisory (01.25.2011)
•Author, Mo V. Spilton And False Claims Penalties , Law360 (01.25.2011)
•Author, Missouri v. Spilton and False Claims Penalties, Law360 (01.2011)
•Author, DOJ and HHS Announce Efforts to Obtain Proactive Data Mining Tools to Supplement Anti-Fraud Efforts , Health Care Enforcement Defense Alert (12.17.2010)
•Author, The NAMFCU Global Newsletter, (10.2008)

Speaking Engagements
• Panelist, Whistleblowers, Compliance and Criminal and Civil Liability for Health Care Fraud: Emerging Strategies for Organizational Response to Non-Compliant Conduct, Enforcement Action and Voluntary Disclosure, 16th Annual ABA Emerging Issues in Healthcare Law , American Bar Association, Lake Buena Vista, FL (03.04.2015)
• Moderator, State Enforcers' Roundtable, In-House Counsel and Pricing Executive Forum on Government Regulation of Prescription Drug Pricing , ACI, New York, NY (06.24.2014)
• Speaker, Multi-State Survey - Adjusting Compliance Programs from Standard Models in order to Meet Varied State Guidelines, National Forum on Pharmaceutical Pricing Litigation Conference , American Conference Institute, Philadelphia, PA (03.21.2014)
• Speaker, Overcoming Challenges Caused by Program, RAC, ZPIC, and MIC Auditors and Contractors: Determining when a Finding of Fraud is Inappropriate and when to Challenge it, Advanced Forum on Healthcare Provider Disputes , American Conference Institute, Miami, FL (03.07.2014)
• Speaker, What Do the Proposed Changes to Medicare Parts C and D Mean for Your Business? , Mintz Levin, Webinar (01.29.2014)
• Speaker, Preventing Whistleblower Actions: Customizing an Effective Qui Tam Avoidance Program , Mintz Levin, Webinar (05.22.2013)
• Panelist, State False Claims Act Practice - Medicaid and Other Frauds at the State Level, False Claims Act: All Points of View , CLE International, San Francisco, CA (04.19.2013)
• Moderator, Survey and Analysis of state Pricing Enforcement Activities, In-House Counsel and Pricing Executive Forum on Government Regulation of Prescription Drug Pricing , American Conference Institute, New York, NY (02.27.2013)
• Speaker, Emerging Issues in the Prosecution and Defense of State Medicaid False Claims Cases , Bloomberg BNA, Webinar (01.09.2013)
• Speaker, Developing Litigation Strategy in Response to the Increase of Qui Tam and Whistleblower Cases Proceeding to Trial, National Forum on Pharmaceutical Pricing Litigation Conference , American Conference Institute, New York, NY (10.03.2012)
• Moderator, State and Federal Enforcers Panel: Adjusting Trial Strategy and Addressing Challenges When Moving into Litigation and/or Settlement, National Forum on Pharmaceutical Pricing Litigation Conference , American Conference Institute, New York, NY (10.02.2012)
• Moderator, State Pricing Enforcement Update: The State Enforcers Speak, In-House Counsel Forum on Government Regulation of Prescription Drug Pricing , American Conference Institute , New York, NY (06.28.2012)
• Speaker, Litigating False Claims Act Cases, ABA National Institute of Health Care Fraud Annual Conference , American Bar Association, Miami Beach, FL (05.13.2011)
• Speaker, State Enforcement and Medicaid Fraud, ABA National Institute of Health Care Fraud Annual Conference , American Bar Association, Miami Beach, FL (05.12.2011)

202.434.7445
Client Rating N/A help_info
Submit a client review

Peer Rating N/A help_info

Areas of Law

  • Health Care Enforcement Defense
  • State & Federal Audits
  • Investigations & Litigation
  • Fraud & Abuse
  • Compliance & Regulatory Counseling
  • White Collar Criminal Defense & Parallel Proceedings
  • Arbitration
  • Mediation & Alternative Dispute Resolution
  • Health Law
  • Privacy & Security
  • Health Care
  • Life Sciences

 

Experience & Credentials

Position

Of Counsel

Admission Details

Admitted in 1981, Missouri
1992, Oregon
District of Columbia
Utah

Law School Attended

Washington University
J.D.

University Attended

George Washington University
B.A.

Associations & Memberships

Professional & Community Involvement
•Co-chair, National Forum on Pharmaceutical Pricing Litigation, American Conference Institute (October 2012)
•P... More

Community Contributions

Contact Information


Office Information
Ellyn L. Sternfield
Of Counsel
 701 Pennsylvania Avenue, N.W.,
Washington, DC 20004-2608

Loading...

Logo
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (Washington, District of Columbia)

About Client Rating
About Peer Rating

Welcome to Martindale-Hubbell® Client Review, a new ratings service that allows you to view and provide feedback on a lawyer or law firm on service and relationship qualities such as Communication Ability, Responsiveness, Quality of Service, and Value for Money.

Determining a Rating

The Client Review Rating is determined through aggregation of validated responses. This compilation of Client Reviews translates to a numerical rating and associate descriptive term on a scale of 1 -5. 1 being lowest as "Rated" and 5 being highest as "Preeminent".

  • 4.5-5.0 Preeminent
  • 3.0-4.4 Distinguished
  • 1-2.9 Rated

Martindale-Hubbell uses a third-party resource to validate that the respondent is a living person, but cannot confirm the lawyer/client relationship, which in many cases is confidential. Clients must affirm that they are a client of the lawyer or firm identified for review at the time of the completed Client Review.

The Reviewers

Those who complete Client Reviews are clients of law firms who hired a lawyer within the last year, whose matter is not pending, and want to share their experience of that lawyer or law firm with other potential clients. Reviewers can be of any type from in-house counsel, corporate executives, small business owners to private individuals, and even sometimes another lawyer in a different jurisdiction.

Anonymity

Client Reviews are anonymous and reviewers' identities are not published; however a summary of basic demographics will be part of the display of responses.

Why do we collect demographics as part of the review?

Those who are researching a lawyer or law firm like to see that there are other clients who might be "like them". This is valuable information contributing to the decision-making process of hiring a lawyer.

Martindale-Hubbell's role

Martindale-Hubbell facilitates the process of Client Review by gathering responses, validating them and aggregating results for display online. The content of the responses are entirely from reviewers, the clients of the firm or lawyer.

It is important to note that Martindale-Hubbell does not undertake to develop Client Reviews for all firms and lawyers. Therefore, the fact that a firm or lawyer has not been reviewed should not be construed unfavorably. Prior results do not guarantee a similar outcome and Martindale-Hubbell accepts no responsibility for the content or accuracy of any review over which Martindale-Hubbell exercises no editorial review or control.